Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia.

Literature DB >> 26376948

Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia.

Ryojun Nakajima¹, Michiyo Ishida¹, Chizuko A Kamiya², Jun Yoshimatsu², Mika Suzuki¹, Asuka Hirota¹, Tomoaki Ikeda³, Toshio Harigaya¹.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2015 PMID： 26376948 DOI： 10.1038/hr.2015.99

Source DB: PubMed Journal: Hypertens Res ISSN： 0916-9636 Impact factor: 3.872

× No keyword cloud information.

9 in total

1. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

Authors: Patricia K Agatisa; Roberta B Ness; James M Roberts; Joseph P Costantino; Lewis H Kuller; Margaret K McLaughlin
Journal: Am J Physiol Heart Circ Physiol Date: 2004-04 Impact factor: 4.733

2. Toward a better understanding of preeclampsia: Comparative proteomic analysis of preeclamptic placentas.

Authors: Young Nam Kim; Hyoung Kyu Kim; Mohamad Warda; Nari Kim; Won Sun Park; Ab Del Bary Prince; Dae Hoon Jeong; Dae Shim Lee; Ki Tae Kim; Jin Han
Journal: Proteomics Clin Appl Date: 2007-11-16 Impact factor: 3.494

3. Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia.

Authors: Carmen González; Adalberto Parra; Jorge Ramírez-Peredo; Celina García; José Carlos Rivera; Yazmín Macotela; Jorge Aranda; Maria Lemini; José Arias; Francisco Ibargüengoitia; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal: Lab Invest Date: 2007-08-06 Impact factor: 5.662

Review 4. Vasoinhibins: endogenous regulators of angiogenesis and vascular function.

Authors: Carmen Clapp; Jorge Aranda; Carmen González; Michael C Jeziorski; Gonzalo Martínez de la Escalera
Journal: Trends Endocrinol Metab Date: 2006-08-23 Impact factor: 12.015

5. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors: Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal: Cell Date: 2007-02-09 Impact factor: 41.582

6. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.

Authors: Akihide Ohkuchi; Chikako Hirashima; Kayo Takahashi; Hirotada Suzuki; Shigeki Matsubara; Mitsuaki Suzuki
Journal: Hypertens Res Date: 2013-08-22 Impact factor: 3.872

7. Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy.

Authors: Jakob Triebel; Michael Huefner; Giuliano Ramadori
Journal: Eur J Endocrinol Date: 2009-05-28 Impact factor: 6.664

8. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes.

Authors: Alfredo Leaños-Miranda; Janeth Márquez-Acosta; Guadalupe María Cárdenas-Mondragón; Zarela Lizbeth Chinolla-Arellano; Roxana Rivera-Leaños; Sara Bermejo-Huerta; Juan Fernando Romero-Arauz; Guadalupe Alvarez-Jiménez; Julio César Ramos-León; Alfredo Ulloa-Aguirre
Journal: J Clin Endocrinol Metab Date: 2008-05-06 Impact factor: 5.958

9. Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida.

Authors: Lalita Kulmala; Vorapong Phupong
Journal: Hypertens Res Date: 2014-03-13 Impact factor: 3.872

9 in total

8 in total

8. Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.

Authors: Jakob Triebel; Christin J Friedrich; Andreas Leuchs; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal: Front Endocrinol (Lausanne) Date: 2017-11-06 Impact factor: 5.555

8 in total

Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia.

1. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

2. Toward a better understanding of preeclampsia: Comparative proteomic analysis of preeclamptic placentas.

3. Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia.

Review 4. Vasoinhibins: endogenous regulators of angiogenesis and vascular function.

5. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

6. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.

7. Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy.

8. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes.

9. Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida.

1. Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase.

2. Upregulation of cathepsin C expression contributes to endothelial chymase activation in preeclampsia.

Review 3. The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Review 4. From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.

5. Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.

6. A Potential Three-Gene-Based Diagnostic Signature for Hypertension in Pregnancy.

Review 7. Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.

8. Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.